Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,000 shares at $419.00 ($838K) on 2020-02-24, disclosed to the SEC on 2020-02-25.
Open-market sale of $838k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $419.00 | 1,956 | $820K | 97.8% |
| 2 | $419.03 | 44 | $18K | 2.2% |
| Total | $419.00 avg | 2,000 | $838K | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |